Principaux concurrents
Rendement du dividende (Y) Rendement du dividende (Y+1) PER (Y) Price to Book (Y) VE / CA (Y) VE / EBITDA (Y) VE / EBIT (Y) Capi.($)
0,6 %0,68 %17.15x1.95x3.68x9.49x10.99x 66,25 Md
0,6 %0,62 %26.07x3.94x5.39x15.85x19.65x 52,86 Md
-.--%-.--%33.98x6.82x11.48x21.98x25.6x 43,01 Md
3,45 %3,55 %-44.33x2.45x3.15x9.3x10.85x 39,52 Md
-.--%-.--%24.04x1.57x3.43x11.65x13.51x 29,19 Md
-.--%-.--%-6.71x4.07x9.37x-5.77x-5.4x 23,04 Md
-.--%-.--%55.87x3.3x3.21x26.87x27.24x 23,13 Md
-.--%0,05 %66.64x5.99x6.57x45.21x51x 20,48 Md
-.--%-.--%24.35x3.57x5.21x13.64x18.86x 16,6 Md
-.--%-.--%-37.32x-6.59x17.71x-48.48x-56.03x 16,2 Md
-.--%-.--%-116.24x12691.74x12.48x-89.37x-124.56x 12,33 Md
-.--%-.--%17.31x - 3.56x13.78x16.09x 11,29 Md
-.--%-.--%45.1x - - - - 9,93 Md
0,19 %0,2 %49.03x19.99x29.56x41.81x43.12x 9,72 Md
2,66 %3,05 %12.85x1.15x1.86x7.49x10.13x 6,74 Md
0,35 %0,41 %29.13x - 7.85x20.82x24.86x 5,95 Md
-.--%-.--%-111.7x - - - - 5,49 Md
Moyenne 0,46 % 0,5 % 5,01x 980,00x 8,30x 6,28x 5,73x 23,04 Md
Moyenne pondérée par Capi. 0,59 % 0,62 % 11,64x 439,22x 6,87x 9,59x 10,44x
Biopharmacies
🔇